Longevity.
healthier, more vibrant lives.
Empowering patients to lead healthier, more vibrant lives.
Aging is linked to the gradual deterioration in biological functions that occurs in most tissues.
Degradation of specific tissues leads to a variety of disorders, including neurodegenerative diseases, obesity, diabetes, cardiovascular diseases, and cancer.
Biolexis' work focuses on defined targets in a unique manner. Our science is driven by a proprietary AI approach.
Unleash the potential of human longevity.
Demographics paint a clear picture: people are living longer with older people representing a growing percentage of the global population. This surge creates a massive and ever-expanding market for products and services that promote healthy aging. Biolexis is positioned to capitalize on this unprecedented opportunity to address an array of chronic diseases.
Biolexis has the ability to rapidly create novel compounds by leveraging a unique AI-driven discovery engine.
“As we continue to research, develop, and implement innovative methods to address critical unmet medical needs, we believe our work targeting GLP-1, AMPK, and mTORC will lead to expanded treatment options not only for obesity and diabetes, but for a broader number of chronic diseases.”
HARIPRASAD VANKAYALAPATI, M.PHARM, PHD